Covid-19 and Vaccination Tied to Neurological Issues in 3.75% of Patients, NIMHANS Study Warns of Stroke, Seizures

Publication date: Jul 17, 2025

Patients ranged in age from 3 to 84 years, with a median age of 49. Symptoms such as altered consciousness (47%), seizures (21%), and loss of smell (14. 2%) were common.

Concepts	Keywords
Diabetes	Complications
Neurosciences	Conditions
September	Covid
Therapists	Including
Viral	Infection
	Long
	Mental
	Neurological
	Nimhans
	Patients
	Seizures
	Stroke
	Symptoms
	Term
	Vaccination

Semantics

Type	Source	Name
disease	MESH	lifestyle
disease	IDO	quality
disease	MESH	hypertension
disease	MESH	morbidities
disease	MESH	memory loss
disease	MESH	cognitive impairment
disease	MESH	long Covid
disease	MESH	meningoencephalitis
disease	MESH	autoimmune responses
disease	MESH	blood clots
disease	MESH	hypoxia
disease	MESH	Neurological Manifestations
drug	DRUGBANK	Tropicamide
disease	MESH	loss of smell
disease	MESH	syndrome
disease	MESH	encephalopathy
disease	MESH	Covid-19
disease	MESH	Stroke
disease	MESH	Seizures
disease	MESH	complications
disease	MESH	infection
disease	MESH	neurological disorders

Original Article

(Visited 2 times, 1 visits today)